<a id="back-btn" href="" ui-sref="ExhibitHall"><i class="fas fa-chevron-left"></i>Back</a>

<h1 class="pod-header">mAb Mechanism of Action &amp; Data</h1>

<div class="pod-menu">
	<img class="pod-header" src="./images/flags/pod-b-header.svg">
	<ul>
		<li>
			<a href="" ui-sref="PodB.1" class="video">
				<span>Video</span>Mechanism of Action of Casirivimab and Imdevimab	
			</a>
		</li>
		<li>
			<a href="" ui-sref="PodB.2" class="infographic">
				<span>Infographic</span>Advantages of Combination Therapy 	
			</a>
		</li>
		<li>
			<a href="" ui-sref="PodB.3" class="infographic">
				<span>Infographic</span>COVID-19 Variants	
			</a>
		</li>
		<li>
			<a class="menu-toggle poster" href="">Data Presentations</a>
			<ul>
				<li>
					<a href="" ui-sref="PodB.4a" class="poster">
						<span>Poster</span>COVID-19 Prevention with Subcutaneous Administration of the Monoclonal Antibodies Casirivimab and Imdevimab
					</a>
				</li>
				<li>
					<a href="" ui-sref="PodB.4b" class="poster">
						<span>Poster</span>Early Treatment of SARS-CoV-2 Infection with Subcutaneous Administration of Casirivimab and Imdevimab
					</a>
				</li>
				<li>
					<a href="" ui-sref="PodB.4c" class="poster">
						<span>Poster</span>Dose-Ranging Virology Study of the Combination COVID-19 Antibodies Casirivimaband Imdevimab in the Outpatient Setting
					</a>
				</li>
				<li>
					<a href="" ui-sref="PodB.4d" class="video">
						<span>Video</span>Casirivimab and Imdevimab, Two Antibodies Against SARS-CoV-2, in the Outpatient Setting: Phase 3 Efficacy and Safety Results
					</a>
				</li>
				<li>
					<a href="" ui-sref="PodB.4e" class="video">
						<span>Video</span>Casirivimab and Imdevimab, Two Antibodies Against SARS-CoV-2, in Mild to Moderate COVID-19: Phase 3 Efficacy and Safety Results Update
					</a>
				</li>
				<li>
					<a href="" ui-sref="PodB.4f" class="video">
						<span>Video</span>Phase 1/2 Antiviral and Clinical Efficacy Primary Results with Casirivimab and Imdevimab, a Cocktail of Two Antibodies Against SARS-CoV-2 Virus, in the Outpatient Setting
					</a>
				</li>
				<li>
					<a href="" ui-sref="PodB.4g" class="video">
						<span>Video</span>Casirivimab with Imdevimab Antibody Cocktail for COVID-19 Prevention: Interim Results
					</a>
				</li>
			</ul>
		</li>
		<li>
			<a href="" ui-sref="PodB.5" class="infographic">
				<span>Infographic</span>COVID-19 Prevention Study Results 	
			</a>
		</li>
		<li>
			<a href="" ui-sref="PodB.6" class="pdf">
				<span>PDF</span>Key Literature	
			</a>
		</li>
		<li>
			<a href="" ui-sref="PodB.7" class="infographic">
				<span>Infographic</span>Casirivimab and Imdevimab, Two Antibodies Against SARS-CoV-2, in Mild to Moderate COVID-19: Phase 3 Efficacy and Safety Results 	
			</a>
		</li>
		<li>
			<a href="" ui-sref="PodB.8" class="infographic">
				<span>Infographic</span>Identifying Appropriate Patients for Treatment with Casirivimab and Imdevimab	
			</a>
		</li>
		<li>
			<a href="" ui-sref="PodB.9" class="infographic">
				<span>Infographic</span>Identifying Appropriate Individuals for Post-Exposure Prophylaxis with Casirivimab and Imdevimab 	
			</a>
		</li>
		
		
	</ul>

</div>

<!--<a id="back-btn" href="" ui-sref="ExhibitHall"><img src="images/icons/back.svg">Go Back</a>-->

<script>
	$(function() {
		$('a.menu-toggle').click(function(e) {
			e.preventDefault();
			$(this).toggleClass('expanded');
		});
	})
</script>

